Leap Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. 

CEO
Doug E. Onsi
CEODoug E. Onsi
Employees
52
Employees52
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2011
Founded2011
Employees
52
Employees52

LPTX Key Statistics

Market cap
13.12M
Market cap13.12M
Price-Earnings ratio
-0.20
Price-Earnings ratio-0.20
Dividend yield
—
Dividend yield—
Average volume
582.37K
Average volume582.37K
High today
$0.318
High today$0.318
Low today
$0.2994
Low today$0.2994
Open price
$0.3126
Open price$0.3126
Volume
471.41K
Volume471.41K
52 Week high
$4.79
52 Week high$4.79
52 Week low
$0.2223
52 Week low$0.2223

People also own

Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
Plug Power
Lucid Group
Ocugen, Inc
FuelCell Energy
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.